Cytodyn Inc (CYDY)

[Hold10]

CYDY is likely TEN YEARS from any approval. timeline provided
"the science" doesn't matter if you don';t get approved.
there is competition in all cancers, and NASH, and HIV, including long acting HIV solutions.
meanwhile, leronlimab needs to start in phase 2 for ALL PIPELINE and ALL OTHER indications.

1 year to even think about starting a trial due to lack of funding,
2.5 years from protocol thru phase 2 top line,
3.5 years from protocol thru phase 3 top line,
1.5 years for any approval process.

total of 8.5 years and that's THE BARE MINIMUM. that is WITH NO DELAYS. there are always delays.

tnbc an awesome example. they designed the trial fine. there was no SOC. but when they were further along, there WAS SOC. trial now need to be started all over again, new protocol and all. and that happens A LOT in pharma. and its more and more likely all the time as so many profound advances are being made every year at an accelerating pace.